2015-01-22 18:10:49 UTC

Infection Risk with Duodenoscopes used for ERCP

Jan. 22, 2015

Patient infections with difficult bacteria, called CRE, after ERCP have been reported and may cause concern for both patients and physicians. AGA leadership has been working with leadership of all other GI societies, FDA and endoscopy manufacturers to help solve this critical patient safety concern.

Patient infections with carbapenem-resistant Enterobacteriaceae (CRE) after ERCP have been reported and may cause concern for both patients and physicians. The problem of infection transmission lies in the complex design of duodenoscopes where the elevator channel can allow bacteria to remain after cleansing, even if reprocessing follows accepted procedures.

Remind patients that the therapeutic benefits of ERCP outweigh the potential low risk of infection.

AGA leadership has been working with leadership of all other GI societies, FDA and endoscopy manufacturers to help solve this critical patient safety concern. Through the AGA Center for GI Innovation and Technology, we have working relationships with the FDA device branch and the endoscope manufacturers, and we are offering our help to resolve and monitor this issue. Our goal is safe patient care with no preventable infections.

More on ERCP

AGA Supports New Government Scope Safety Protocols

Feb. 28, 2018

While voluntary, AGA encourages GIs to review and consider adopting sampling and culturing of reprocessed duodenoscopes.

Attend the AGA Postgraduate Course for Practical, Take Home Information

Feb. 12, 2018

Join us on June 2-3 in Washington, D.C. This course is held in conjunction with Digestive Disease Week® (DDW) 2018.

Voluntary Recall of Pentax ED-3490TK Duodenoscopes

Feb. 8, 2018

Recall designed to reduce the potential for leakage of patient fluids into the closed elevator channel and under the distal cap.